These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16788795)

  • 1. [Success and failure in interdisciplinary studies].
    Schwarz R
    Urologe A; 2006 Jun; 45(6):766-7. PubMed ID: 16788795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiotherapy versus radiotherapy plus hormone therapy in the case of isolated PSA increase after radical prostatectomy. A prospective multicenter Phase III study of the AUO (AP 26/99) and the ARO (00/01)].
    Schwarz R; Rexer H
    Urologe A; 2004 Feb; 43(2):194-6. PubMed ID: 14991123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Hammerer P
    Aktuelle Urol; 2004 Sep; 35(5):371-2. PubMed ID: 15384001
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
    Wiegel T; Bartkowiak D; Bottke D; Bronner C; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Stöckle M; Rübe C; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hofmann R; Engenhart-Cabillic R; Hinke A; Hinkelbein W; Miller K
    Eur Urol; 2014 Aug; 66(2):243-50. PubMed ID: 24680359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.
    Montgomery B; Lavori P; Garzotto M; Lee K; Brophy M; Thaneemit-Chen S; Kelly W; Basler J; Ringer R; Yu W; Whittemore A; Lin DW
    Urology; 2008 Sep; 72(3):474-80. PubMed ID: 18407333
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant radiotherapy in lymph-node-positive prostate cancer with low tumor burden after radical prostatectomy : Multicenter randomized phase III trial on the effect of adjuvant radio therapy in patients with prostate cancer with or without positive margins after radical prostatectomy (RP) and lymph node metastasis with low tumor burden (micrometastases, ≤ 2 lymph node macrometastases). ART-2 trial AP 61/11 of the AUO].
    Rexer H; Bartkowiak D
    Urologe A; 2015 Jun; 54(6):871-4. PubMed ID: 26081820
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving outcomes in early prostate cancer: Part I--adjuvant treatment.
    Mazhar D; Ngan S; Waxman J
    BJU Int; 2006 Oct; 98(4):725-30. PubMed ID: 16978266
    [No Abstract]   [Full Text] [Related]  

  • 8. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study landscape for prostate cancer].
    Miller K
    Urologe A; 2005 Dec; 44(12):1431-4. PubMed ID: 16292461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?
    Ganswindt U; Stenzl A; Bamberg M; Belka C
    Eur Urol; 2008 Sep; 54(3):528-42. PubMed ID: 18602742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
    Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
    J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Target volume for adjuvant radiotherapy after prostatectomy].
    Bossi A
    Cancer Radiother; 2007 Nov; 11(6-7):358-62. PubMed ID: 17888706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death of a clinical trial: a speculative inclusion criterion gone wrong.
    Rosenthal MA; Woo H; Gurney H; Copeman M; Zingarelli G
    Intern Med J; 2007 Dec; 37(12):838-9. PubMed ID: 18028092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment option for pT3 patient after radical prostatectomy].
    Sugimura Y; Wakita T; Mizogam A
    Hinyokika Kiyo; 2005 Sep; 51(9):571-3. PubMed ID: 16229368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hospital volume on cancer control after radical prostatectomy.
    Ellison LM; Trock BJ; Poe NR; Partin AW
    J Urol; 2005 Jun; 173(6):2094-8. PubMed ID: 15879850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options for a rising PSA after radical prostatectomy.
    Carthon BC; Marcus DM; Herrel LA; Jani AB; Rossi PJ; Canter DJ
    Can J Urol; 2013 Jun; 20(3):6748-55. PubMed ID: 23783041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: a practical approach to current management of recurrent disease.
    Walczak JR; Carducci MA
    Mayo Clin Proc; 2007 Feb; 82(2):243-9. PubMed ID: 17290734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy.
    Tzou K; Tan WW; Buskirk S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):125-36. PubMed ID: 21166517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Ohlmann C; Heidenreich A
    Aktuelle Urol; 2004 Sep; 35(5):372-4. PubMed ID: 15478268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.